Loading…
Based on limited metadata, Ionogen, LLC received an FDA Warning Letter on July 7, 2020, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the complete scope and details of the regulatory concerns, access to the full Warning Letter would be necessary.